key: cord-0922896-ceyt33on
authors: Ahmad, Usman
title: Commentary: Lung Donation after Circulatory Death in the United States. Current and Future Challenges
date: 2020-05-15
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2020.04.156
sha: a53a7fdf9b49d64523a9596ad2aef5fd2ff3ef32
doc_id: 922896
cord_uid: ceyt33on

nan

Central Message: Lung donation from DCD remains low. Variability in practice exists across regions and programs. Increasing awareness and standardization is necessary in order to preserve and expand this donor pool.

In early and mid 2000s, reports of lung allograft donation after circulatory death (DCD) and their successful utilization created some much needed enthusiasm and hope that organ shortage could be mitigated to some extent [1] [2] [3] . The Toronto lung transplant program reported utilization of DCD lungs to increase from 0% in 2006 to 27% in 2008 [4] . Around the same time, 36 DCD lungs were transplanted in the United States between 1987 and 2007 [5] . These as well as more recent data published by the International Society of heart and lung transplantation, showed reasonable recipient 5-year survival which was comparable to survival after transplantation with lungs from brain dead donors (DBD) [6] . Despite these findings and the continued discrepancy between number of available organs and listed patients, there continues to be a surprising amount of apprehension surrounding the use of DCD lungs by transplant programs as well as by the organ procurement organizations (OPO).

Some of the technical and logistic issues surrounding utilization of DCD lungs continue to be a challenge in increasing adoption of DCD practice. For example the higher uncertainty of dry run, inability to thoroughly assess organs intraoperatively before procurement, inability to recruit and monitor gas exchange in real-time along with time constraints imposed by DCD donation decrease the appeal of DCD donation/procurement. Identifying additional pre-procurement factors that may predispose a donor to either not be approached or allocated is important in modifying practice to help increase donor utilization.

Choi and colleagues [7] have undertaken this timely study to evaluate the risk factors for nonutilization of lungs from DCD donors. Over a 15 -year time period, 15,458 DCD donors (30,916 lungs) were evaluated and only 3.7% were utilized for clinical transplantation. This is in stark contrast to 22.4% of lungs from brain-dead donors being utilized over the same time period. The vast proportion of organs in each group were just not recovered (DCD-73%, DBD 63%). Donor factors associated with nonutilization of DCD lungs included low P/F ratio, history of smoking and older age.

Parsing through reasons of non-utilization revealed that a consent was not obtained in 4.6% of DCD and 2.6% of DBD cases. It is very interesting to note however that a consent was not requested for 8.4% of DCD donors as opposed to only 2.2% DBD donors, highlighting differences in OPO practices and perhaps perceptions. On a similar note regional differences in DCD donation were also noted. Among these findings the practice of not approaching donor families to consent appears to be the most readily modifiable factor. This missed opportunity could potentially have added close to 100 (at 3.7% transplantation rate) lungs to the DCD donor lung pool during this time period. This is a remarkable finding that opens up avenues for improving education and changing perception at the OPO level. It is important to note that a significant share of this responsibility lies upon the local transplant centers.

In the United States, we are entering a unique era where supportive technologies such as ex vivo lung perfusion allow transplant programs to evaluate DCD, extended criteria or marginal organs over extended time periods potentially overcoming some of the above mentioned logistic issues and increasing the number of available transplantable organs. However, at the same time, newer allocation policies such as replacement of Donation Service Area (DSA) with a 250 nautical mile radius are expected to decrease traditional "local" donation, increase travel distance and cost and potentially decrease the appeal for programs to evaluate donors with uncertain outcomes such as DCD. Fortunately the 2 year outcomes show increase in total number of DCD in the post policy change era with regional variability [8] . Remarkably regions 7,9 and To add insult to injury, US Centers for Medicare and Medicaid Services has proposed new standards that will require OPOs to stay close to or above the 75 th percentile (among OPOS) in both organ donation and organ transplantation rates [10]. This may force OPOs to prefer donors and organs with higher chance of acceptance for transplantation and may pose additional challenges to DCD lung donation and utilization.

The importance of this work in understanding factors associated with DCD non-utilization cannot be overstated. Transplant centers need to appreciate these challenges and rate limiting steps surrounding organ availability. I would like to re-iterate the importance of building a strong partnership with OPOs, to change perceptions, increase awareness and perhaps eventually narrow the supply demand gap in lung transplantation.

Significant variability in practice exists between various programs and regions. Programs accept varying level of "risk" depending on the program's comfort level and perhaps based on severity of recipient illness. Standardization of at least some practices such as length of agonal time, broader use of EVLP and broader sharing of procurement resources may also allow transplant centers across the country to utilize more DCD donors.

Transplantation of lungs from a non-heart-beating donor

Evaluation of techniques for lung transplantation following donation after cardiac death

Early lung transplantation success utilizing controlled donation after cardiac death donors

Initial experience with lung donation after cardiocirculatory death in Canada

Should lung transplantation be performed using donation after cardiac death? The United States experience

Donation after circulatory death in lung transplantation-fiveyear follow-up from ISHLT Registry

Predictors of Non-utilization of Donation Af 49 ter Circulatory Death Lung Allografts

Organ Procurement and Transplantation Network Thoracic Transplantation Committee. Monitoring of the Lung Allocation Change, 2 Year Report Removal of DSA as a Unit of Allocation

The Centers for Medicare and Medicaid Services' proposed metrics for recertification of organ procurement organizations: Evaluation by the Scientific Registry of Transplant Recipients